https://the-limbic-sponsored-podcasts.simplecast.com 2024-03-25 1 https://the-limbic-sponsored-podcasts.simplecast.com/episodes 2024-03-25 0.9 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/selinexor-in-relapsed-refractory-multiple-myeloma-international-experience-2LAdmBux 2024-03-25 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/after-pbs-changes-for-tpo-ras-in-itp-where-are-we-now-fxv81VaE 2024-03-21 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/managing-adults-with-x-linked-hypophosphataemia-ZGPGKial 2024-03-12 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/xadago-for-parkinsons-disease-australian-clinical-experience-3vpiYy3x 2024-02-07 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/perspectives-from-ims-2023-targeted-therapies-for-myeloma-pTFwuloI 2023-11-20 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/perspectives-from-ims-2023-immunotherapy-updates-_n4Z3IN7 2023-11-20 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/clinical-pathway-for-coronary-atherosclerosis-in-smurf-less-patients-1C7PZG7O 2023-11-07 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/mylotarg-in-aml-dosing-schedules-NBF2XmHr 2023-10-30 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/mylotarg-in-aml-adverse-event-management-iG97NCoY 2023-10-30 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/mylotarg-in-aml-which-patients-are-suitable-for-treatment-ApOMAGgD 2023-10-30 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/deucravacitinib-in-moderate-to-severe-plaque-psoriasis-expert-perspective-ofV7ZqBI 2023-10-26 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/clinical-experience-with-drf-practical-tips-for-patient-management-PHXLBaeh 2023-08-24 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/perspectives-on-the-current-status-of-r-r-all-management-rPsTK2kV 2023-08-18 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/epidyolex-for-lennox-gastaut-syndrome-clinical-perspectives-HvoX4Lwv 2023-07-25 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/zanubrutinib-in-cll-expert-perspectives-sY2rmTFq 2023-07-18 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/reflections-on-baricitinib-real-world-data-1iA24QXX 2023-06-15 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/cardiovascular-health-in-the-covid-era-QuUMzRzX 2023-05-31 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/a-call-to-arms-for-biomarker-driven-care-in-severe-asthma-axcC_YZ_ 2023-05-08 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/the-potential-role-of-antibody-drug-conjugates-lmCHEqQG 2023-02-13 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/place-in-therapy-of-currently-available-immune-checkpoint-inhibitors-w3T4VCyJ 2023-02-13 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/the-place-in-therapy-of-immune-checkpoint-inhibitors-Gr_Kuejb 2023-02-09 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/tangible-steps-to-better-adherence-strategies-for-post-acs-secondary-prevention-cbjk1zrn-U7yX2JZ9 2023-01-25 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/neuromodulation-as-a-treatment-option-for-drug-resistant-epilepsy-who-why-and-when-izRSBquO 2023-01-23 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/nstemi-reassessing-the-treatment-risk-paradox-z_v0jVn3 2022-11-22 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/immune-competence-in-cll-can-it-be-improved-d0gxe2a5 2022-11-14 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/vumerity-for-rrms-gi-tolerability-considerations-NvQxazBX 2022-10-26 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/wm-msag-guidelines-FfEP4JUF 2022-09-28 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ribociclib-in-advanced-breast-cancer-monaleesa-insights-5cn3Hmuz 2022-09-19 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ep-2-clinical-insights-into-epidyolex-a-cannabis-based-antiseizure-medication-VCZAM_XZ 2022-09-14 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ep-1-clinical-insights-into-epidyolex-a-cannabis-based-antiseizure-medication-_IRspfnK 2022-09-14 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/ibrutinib-in-rr-mcl-insights-from-10-year-data-2iY5zh1R 2022-09-07 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/tangible-steps-to-better-adherence-strategies-for-post-acs-secondary-prevention-UR9_95f8 2022-08-19 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/dapt-who-when-and-for-how-long-FP_aWAoY 2022-08-19 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/treatment-considerations-for-crohns-disease-tk3iGOmq 2022-08-16 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/treat-to-target-in-crohns-disease-2T1r_xyo 2022-08-16 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/new-heart-failure-consensus-statement-what-you-need-to-know-4XXGtvhu 2022-07-28 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/part-two-pharmacotherapy-options-for-weight-loss-o1SlIfgp 2022-07-18 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/clinical-approaches-to-weight-management-B5KMQcR_ 2022-07-18 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/options-for-lenalidomide-refractory-mm-patients-lessons-from-optimismm-287T_71_ 2022-06-14 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/what-is-the-urgency-post-acs-to-mitigate-risk-beyond-the-acute-emergency-and-whose-job-is-it-anyway-fZLGMGsh 2022-06-03 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/waldenstrom-macroglobulinemia-Gw3Tuizo 2021-12-08 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/precision-oncology-in-hepatocellular-carcinoma-qS5IMiT4 2021-11-29 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/precision-medicine-and-companion-diagnostics-for-oncologists-testing-reporting-and-actionability-KIkI5b_l 2021-11-08 0.8 https://the-limbic-sponsored-podcasts.simplecast.com/episodes/cladribine-considerations-in-the-era-of-covid-19-nNTFh9Lw 2021-10-05 0.8